Retraction Note: ICB3E induces iNOS expression by ROS-dependent JNK and ERK activation for apoptosis of leukemic cells (Apoptosis, (2012), 17, 6, (612-626), 10.1007/s10495-011-0695-9);ICB3E induces iNOS expression by ROS-dependent JNK and ERK activation for apoptosis of leukemic cells

Apoptosis

Volumn 17, Issue 6, 2012, Pages 612-626

  Biswas, Nabendu ^a   Mahato, Sanjit K ^a   Chowdhury, Avik Acharya ^a   Chaudhuri, Jaydeep ^a   Manna, Anirban ^a   Vinayagam, Jayaraman ^a   Chatterjee, Sourav ^a   Jaisankar, Parasuraman ^a   Chaudhuri, Utpal ^b   Bandyopadhyay, Santu ^a  

^a INDIAN INSTITUTE OF CHEMICAL BIOLOGY   (India)

^b MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

Apoptosis; c Jun N terminal kinase; Extracellular signal regulated; Inducible nitric oxide synthase; Nitric oxide; Reactive oxygen species

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CYCLIN B1; CYCLIN DEPENDENT KINASE 2; DEATH RECEPTOR 5; FAS ANTIGEN; ICB3E; INDUCIBLE NITRIC OXIDE SYNTHASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; NEUTRALIZING ANTIBODY; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; REACTIVE OXYGEN METABOLITE; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL DEATH; CELL STRAIN 3T3; CELL STRAIN K 562; CHIMERA; CHRONIC MYELOID LEUKEMIA; CYTOTOXICITY; ENZYME ACTIVATION; EPITHELIUM CELL; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; KIDNEY CELL; LEUKEMIA CELL; MITOCHONDRION; MOUSE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; VERO CELL;

PIPER BETLE;

EID: 84862501593     PISSN: 13608185     EISSN: 1573675X     Source Type: Journal    
DOI: 10.1007/s10495-024-02007-7     Document Type: Erratum

References (57)

1. Waypa GB, Guzy R, Mungai PT et al (2006) Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circ Res 99:970-978 (Pubitemid 44657800)
2. Mansfield KD, Simon MC, Keith B (2004) Hypoxic reduction in cellular glutathione levels requires mitochondrial reactive oxygen species. J Appl Physiol 97:1358-1366 (Pubitemid 39299352)
3. Guzy RD, Hoyos B, Robin E et al (2005) Mitochondrial complex III is required for hypoxia-induced ROS production and cellular oxygen sensing. Cell Metab 1:401-408 (Pubitemid 43960623)
4. Ostadal P, Elmoselhi AB, Zdobnicka I, Lukas A, Elimban V, Dhalla NS (2004) Role of oxidative stress in ischemia-reperfusion- induced changes in Na+, K+-ATPase isoform expression in rat heart. Antioxid Redox Signal 6:914-923 (Pubitemid 39237944)
5. Nojiri H, Shimizu T, Funakoshi M et al (2006) Oxidative stress causes heart failure with impaired mitochondrial respiration. J Biol Chem 281:33789-33801 (Pubitemid 46036756)
6. Morgan WA (1995) DNA single-strand breakage in mammalian cells induced by redox cycling quinones in the absence of oxidative stress. J Biochem Toxicol 10:227-232
7. Trachootham D, Alexandre J, Huang P (2009) Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat Rev Drug Discov 8:579-591
8. Toyokuni S, Okamoto K, Yodoi J, Hiai H (1995) Persistent oxidative stress in cancer. FEBS Lett 358:1-3
9. Pelicano H, Carney D, Huang P (2004) ROS stress in cancer cells and therapeutic implications. Drug Resist Updat 7:97-110 (Pubitemid 38736063)
10. Syng-Ai C, Kumari AL, Khar A (2004) Effect of curcumin on normal and tumor cells: role of glutathione and bcl-2. Mol Cancer Ther 3:1101-1108 (Pubitemid 39295007)
11. Torres M, Forman HJ (2003) Redox signaling and the MAP kinase pathways. Biofactors 17:287-296 (Pubitemid 37267162)
12. Ueda S, Masutani H, Nakamura H, Tanaka T, Ueno M, Yodoi J (2002) Redox control of cell death. Antioxid Redox Signal 4:405-414 (Pubitemid 34753380)
13. Desbarats J, Birge RB, Mimouni-Rongy M, Weinstein DE, Palerme JS, Newell MK (2003) Fas engagement induces neurite growth through ERK activation and p35 upregulation. Nat Cell Biol 5:91-92
14. Kim J, Adam RM, Freeman MR (2002) Activation of the ERK mitogen-activated protein kinase pathway stimulates neuroendocrine differentiation in LNCaP cells independently of cell cycle withdrawal and STAT3 phosphorylation. Cancer Res 62:1549-1554 (Pubitemid 34407821)
15. Wang X, Martindale JL, Liu Y, Holbrook NJ (1998) The cellular response to oxidative stress: influences of mitogen-activated protein kinase signalling pathways on cell survival. Biochem J 333:291-300 (Pubitemid 28379529)
16. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270:1326-1331
17. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH (1996) The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271: 31929-31936 (Pubitemid 26422216)
18. Graves JD, Draves KE, Craxton A, Saklatvala J, Krebs EG, Clark EA (1996) Involvement of stress-activated protein kinase and p38 mitogen-activated protein kinase in mIgM-induced apoptosis of human B lymphocytes. Proc Natl Acad Sci 93:13814-13818
19. Brenner B, Koppenhoefer U, Weinstock C, Lind ER Kamp O, Lang F, Gulbins E (1997) Fas- or ceramide-induced apoptosis ismediated by a Rac1-regulated activation of Jun N-terminal kinase/p38 kinases and GADD153. J Biol Chem 272:22173-22181 (Pubitemid 27382847)
20. Wang X, Martindale JL, Holbrook NJ (2000) Requirement for ERK activation in cisplatin-induced apoptosis. J Biol Chem 275: 39435-39443 (Pubitemid 32058968)
21. Zhuang S, Schnellmann RG (2006) A death-promoting role for extracellular signal-regulated kinase. J Pharmacol Exp Ther 19: 991-997
22. Chakraborty JB, Mahato SK, Joshi K et al (2012) Hydroxychavicol, a Piper betle leaf component, induces apoptosis of CML cells through mitochondrial reactive oxygen species-dependent JNK and endothelial nitric oxide synthase activation and overrides imatinib resistance. Cancer Sci 103:88-99. doi:10.1111/j.1349-7006.2011.02107.x [Epub ahead of print]
23. Amonkar AJ, Nagabhushan M, D'Souza AV, Bhide SV (1986) Hydroxychavicol: a new phenolic antimutagen from betel leaf. Food Chem Toxicol 24:1321-1324 (Pubitemid 17215893)
24. Nagabhushan M, Amonkar AJ, Nair UJ, D'Souza AV, Bhide SV (1989) Hydroxychavicol: a new anti-nitrosating phenolic compound from betel leaf. Mutagenesis 4:200-204 (Pubitemid 19128781)
25. Chang MC, Uang BJ, Wu HL, Lee JJ, Hahn LJ, Jeng JH (2002) Inducing the cell cycle arrest and apoptosis of oral KB carcinoma cells by hydroxychavicol: roles of glutathione and reactive oxygen species. Br J Pharmacol 135:619-630 (Pubitemid 34177639)
26. Perkin WM Jr, Trikojus VM (1927) Synthesis of safrole and o-safrole. J Chem Soc, pp 1663-1666
27. Sethi SC, Subba Rao BC (1964) Synthesis of 4-allylpyrocatechol and mechanism of Claisen rearrangement in o-dihydroxy compounds. Indian J Chem 2:323-326
28. Kankaanranta H, De Souza PM, Barnes PJ, Salmon M, Giembycz MA, Lindsay MA (1999) SB 203580, an inhibitor of p38 mitogen- activated protein kinase, enhances constitutive apoptosis of cytokine-deprived human eosinophils. J Pharmacol Exp Ther 290:621-628 (Pubitemid 29344554)
29. Zelivianski S, Spellman M, Kellerman M et al (2003) ERK inhibitor PD98059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells. Int J Cancer 107:478-485 (Pubitemid 37266470)
30. Heikkila RE, Cabbat FS, Cohen G (1976) In vivo inhibition of superoxide dismutase in mice by diethyldithiocarbamate. J Biol Chem 251:2182-2185
31. Salvi M, Battaglia V, Brunati AM et al (2007) Catalase takes part in rat liver mitochondria oxidative stress defense. J Biol Chem 282:24407-24415 (Pubitemid 47328021)
32. Lozzio CB, Lozzio BB (1975) Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45:321-334
33. Bandyopadhyay G, Biswas T, Roy KC et al (2004) Chlorogenic acid inhibits Bcr-Abl tyrosine kinase and triggers p38 mitogen-activated protein kinase-dependent apoptosis in chronic myelogenous leukemic cells. Blood 104:2514-2522 (Pubitemid 39331855)
34. Friis MB, Friborg CR, Schneider L et al (2005) Cell shrinkage as a signal to apoptosis in NIH 3T3 fibroblasts. J Physiol 567: 427-443 (Pubitemid 41301043)
35. Ravindra PV, Tiwari AK, Ratta B et al (2008) Induction of apoptosis in Vero cells by Newcastle disease virus requires viral replication, de novo protein synthesis and caspase activation. Virus Res 133:285-290
36. Thompson HG, Harris JW, Wold BJ, Lin F, Brody JP (2003) p62 overexpression in breast tumors and regulation by prostate-derived Ets factor in breast cancer cells. Oncogene 22:2322-2333 (Pubitemid 36566787)
37. Granillo OM, Brahmajothi MV, Li S et al (2008) Pulmonary alveolar epithelial uptake of S-nitrosothiols is regulated by L-type amino acid transporter. Am J Physiol Lung Cell Mol Physiol 295:L38-L43
38. Rakshit S, Bagchi J, Mandal L et al (2009) N-acetyl cysteine enhances imatinib-induced apoptosis of Bcr-Abl+ cells by endothelial nitric oxide synthase-mediated production of nitric oxide. Apoptosis 14:298-308
39. Carter WO, Narayanan PK, Robinson JP (1994) Intracellular hydrogen peroxide and superoxide anion detection in endothelial cells. J Leukoc Biol 55:253-258
40. Kirkland RA, Saavedra GM, Franklin JL (2007) Rapid activation of antioxidant defenses by nerve growth factor suppresses reactive oxygen species during neuronal apoptosis: evidence for a role in cytochrome c redistribution. J Neurosci 27:11315-11326 (Pubitemid 47621307)
41. Chen CL, Chi CW, Liu TY (2000) Enhanced hydroxychavicol-induced cytotoxic effects in glutathione-depleted HepG2 cells. Cancer Lett 155:29-35
42. Ilangovan R, Marshall WL, Hua Y, Zhou J (2003) Inhibition of apoptosis by Z-VAD-fmk in SMN-depleted S2 cells. J Biol Chem 278:30993-30999 (Pubitemid 36994612)
43. Cowburn AS, White JF, Deighton J, Walmsley SR, Chilvers ER (2005) z-VAD-fmk augmentation of TNF alpha-stimulated neutrophil apoptosis is compound specific and does not involve the generation of reactive oxygen species. Blood 105:2970-2972 (Pubitemid 40446294)
44. Ozoren N, Kim K, Burns TF, Dicker DT, Moscioni AD, El-Deiry WS (2000) The caspase 9 inhibitor Z-LEHD-FMK protects human liver cells while permitting death of cancer cells exposed to tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res 60:6259-6265
45. Tournier C, Hess P, Yang DD et al (2000) Requirement of JNK for stress-induced activation of the cytochrome c-mediated death pathway. Science 288:870-874 (Pubitemid 30257738)
46. Kurata S (2000) Selective activation of p38 MAPK cascade and mitotic arrest caused by low level oxidative stress. J Biol Chem 275:23413-23416
47. El-Najjar N, Chatila M, Moukadem H et al (2010) Reactive oxygen species mediate thymoquinone-induced apoptosis and activate ERK and JNK signaling. Apoptosis 15:183-195
48. Liu TH, Beckman JS, Freeman BA, Hogan EL, Hsu CY (1989) Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am J Physiol 256:H589-H593
49. Cai H, Li Z, Dikalov S et al (2002) NAD(P)H oxidase-derived hydrogen peroxide mediates endothelial nitric oxide production in response to angiotensin II. J Biol Chem 277:48311-48317 (Pubitemid 35470785)
50. Watanabe T, Pakala R, Katagiri T, Benedict CR (2001) Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104:16-18 (Pubitemid 32623283)
51. Dodd-O JM, Pearse DB (2000) Effect of the NADPH oxidase inhibitor apocynin on ischemia-reperfusion lung injury. Am J Physiol Heart Circ Physiol 279:H303-H312 (Pubitemid 30616674)
52. Bulua AC, Simon A, Maddipati R et al (2011) Mitochondrial reactive oxygen species promote production of proinflammatory cytokines and are elevated in TNFR1-associated periodic syndrome (TRAPS). J Exp Med 208:519-533
53. Doehner W, Schoene N, Rauchhaus M et al (2002) Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 105:2619-2624 (Pubitemid 34596038)
54. Kristof AS, Marks-Konczalik J, Moss J (2001) Mitogen-activated protein kinases mediate activator protein-1-dependent human inducible nitric-oxide synthase promoter activation. J Biol Chem 276:8445-8452
55. Pawate S, Bhat NR (2006) C-Jun N-terminal kinase (JNK) regulation of iNOS expression in glial cells: predominant role of JNK1 isoform. Antioxid Redox Signal 8(5-6):903-909 (Pubitemid 44036507)
56. Fukumura D, Kashiwagi S, Jain RK (2006) The role of nitric oxide in tumour progression. Nat Rev Cancer 6:521-534 (Pubitemid 43980541)
57. Kristof AS, Fielhaber J, Triantafillopoulos A, Nemoto S, Moss J (2006) Phosphatidylinositol 3-kinase-dependent suppression of the human inducible nitric-oxide synthase promoter is mediated by FKHRL1. J Biol Chem 281:23958-23968 (Pubitemid 44274170)